Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
在铂类耐药或原发性铂类难治性卵巢癌中,西地尼布联合奥拉帕尼与单用西地尼布或奥拉帕尼,或化疗的疗效比较:NRG-GY005
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00683
Lee, Jung-Min; Brady, Mark F; Miller, Austin; Moore, Richard G; MacKay, Helen; McNally, Leah; Lea, Jayanthi; Street, Daron; Lheureux, Stephanie; McDonald, Megan E; Duska, Linda R; Cantuaria, Guilherme; Kavecansky, Juraj; Leath, Charles A 3rd; Powell, Matthew; Cadungog, Mark G; Rose, Peter G; Kim, Yong-Man; Huang, Helen Q; Provencher, Michèle; Wenzel, Lari B; Bookman, Michael A; Kohn, Elise C; Secord, Angeles Alvarez